Cargando…

Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate

Currently, there are no commercially available live‐attenuated vaccines against chikungunya virus (CHIKV). Here, CHIKVs with mutations in non‐structural proteins (nsPs) were investigated for their suitability as attenuated CHIKV vaccines. R532H mutation in nsP1 caused reduced infectivity in mouse ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Yi‐Hao, Teo, Teck‐Hui, Utt, Age, Tan, Jeslin JL, Amrun, Siti Naqiah, Abu Bakar, Farhana, Yee, Wearn‐Xin, Becht, Etienne, Lee, Cheryl Yi‐Pin, Lee, Bernett, Rajarethinam, Ravisankar, Newell, Evan, Merits, Andres, Carissimo, Guillaume, Lum, Fok‐Moon, Ng, Lisa FP
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554673/ https://www.ncbi.nlm.nih.gov/pubmed/31015278 http://dx.doi.org/10.15252/emmm.201810092

Ejemplares similares

Plasmodium co-infection protects against chikungunya virus-induced pathologies
por: Teo, Teck-Hui, et al.
Publicado: (2018)

Novel differential linear B‐cell epitopes to identify Zika and dengue virus infections in patients
por: Amrun, Siti Naqiah, et al.
Publicado: (2019)

Novel differential linear B‐cell epitopes to identify Zika and dengue virus infections in patients
por: Amrun, Siti Naqiah, et al.
Publicado: (2020)

Viperin controls chikungunya virus–specific pathogenic T cell IFNγ Th1 stimulation in mice
por: Carissimo, Guillaume, et al.
Publicado: (2019)

VCP/p97 Is a Proviral Host Factor for Replication of Chikungunya Virus and Other Alphaviruses
por: Carissimo, Guillaume, et al.
Publicado: (2019)

Type I interferon shapes the quantity and quality of the anti‐Zika virus antibody response
por: Lee, Cheryl Yi‐Pin, et al.
Publicado: (2020)

Immunological observations and transcriptomic analysis of trimester‐specific full‐term placentas from three Zika virus‐infected women
por: Lum, Fok‐Moon, et al.
Publicado: (2019)

Versatile Trans-Replication Systems for Chikungunya Virus Allow Functional Analysis and Tagging of Every Replicase Protein
por: Utt, Age, et al.
Publicado: (2016)

Malaria abrogates O’nyong–nyong virus pathologies by restricting virus infection in nonimmune cells
por: Torres-Ruesta, Anthony, et al.
Publicado: (2022)

Bortezomib inhibits chikungunya virus replication by interfering with viral protein synthesis
por: Kaur, Parveen, et al.
Publicado: (2020)

Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays
por: Pohjala, Leena, et al.
Publicado: (2011)

Virus infection drives IL-2 antibody complexes into pro-inflammatory agonists in mice
por: Lee, Wendy W. L., et al.
Publicado: (2016)

Systematic analysis of disease‐specific immunological signatures in patients with febrile illness from Saudi Arabia
por: Kam, Yiu‐Wing, et al.
Publicado: (2020)

Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease’s active site cysteine residue
por: Rausalu, Kai, et al.
Publicado: (2016)

Multimodal assessments of Zika virus immune pathophysiological responses in marmosets
por: Lum, Fok-Moon, et al.
Publicado: (2018)

Co‐infection with Chikungunya virus alters trafficking of pathogenic CD8(+) T cells into the brain and prevents Plasmodium‐induced neuropathology
por: Teo, Teck‐Hui, et al.
Publicado: (2017)

TREM-1 activation is a potential key regulator in driving severe pathogenesis of enterovirus A71 infection
por: Amrun, Siti Naqiah, et al.
Publicado: (2020)

Occurrence of 4 Dengue Virus Serotypes and Chikungunya Virus in Kilombero Valley, Tanzania, During the Dengue Outbreak in 2018
por: Chipwaza, Beatrice, et al.
Publicado: (2020)

Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology
por: Teo, Teck-Hui, et al.
Publicado: (2015)

Limitations of Current in Vivo Mouse Models for the Study of Chikungunya Virus Pathogenesis
por: Chan, Yi-Hao, et al.
Publicado: (2015)

Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection
por: Chan, Yi-Hao, et al.
Publicado: (2020)

Longitudinal Study of Cellular and Systemic Cytokine Signatures to Define the Dynamics of a Balanced Immune Environment During Disease Manifestation in Zika Virus–Infected Patients
por: Lum, Fok-Moon, et al.
Publicado: (2018)

Expanding Regulatory T Cells Alleviates Chikungunya Virus-Induced Pathology in Mice
por: Lee, Wendy W. L., et al.
Publicado: (2015)

Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections
por: Kam, Yiu-Wing, et al.
Publicado: (2017)

Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response
por: Her, Zhisheng, et al.
Publicado: (2015)

Functions of Chikungunya Virus Nonstructural Proteins
por: Ahola, Tero, et al.
Publicado: (2016)

Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19
por: Carissimo, Guillaume, et al.
Publicado: (2020)

Zika Virus Infection Preferentially Counterbalances Human Peripheral Monocyte and/or NK Cell Activity
por: Lum, Fok-Moon, et al.
Publicado: (2018)

Antiviral activity of silymarin against chikungunya virus
por: Lani, Rafidah, et al.
Publicado: (2015)

nsP4 Is a Major Determinant of Alphavirus Replicase Activity and Template Selectivity
por: Lello, Laura Sandra, et al.
Publicado: (2021)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
por: Amrun, Siti Naqiah, et al.
Publicado: (2020)

Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant
por: Lee, Cheryl Yi‐Pin, et al.
Publicado: (2021)

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection
por: Fong, Siew-Wai, et al.
Publicado: (2021)

Correction to: Robust Virus‐Specific Adaptive Immunity in COVID‐19 Patients with SARS‐CoV‐2 Δ382 Variant Infection
por: Fong, Siew‐Wai, et al.
Publicado: (2021)

RIG-I and MDA-5 Detection of Viral RNA-dependent RNA Polymerase Activity Restricts Positive-Strand RNA Virus Replication
por: Nikonov, Andrei, et al.
Publicado: (2013)

Decreased Virulence of Ross River Virus Harboring a Mutation in the First Cleavage Site of Nonstructural Polyprotein Is Caused by a Novel Mechanism Leading to Increased Production of Interferon-Inducing RNAs
por: Liu, Xiang, et al.
Publicado: (2018)

Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection
por: Roques, Pierre, et al.
Publicado: (2018)

Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity
por: Lum, Fok-Moon, et al.
Publicado: (2018)

A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection
por: Teng, Terk-Shin, et al.
Publicado: (2015)

Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients
por: Ong, Sean Wei Xiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4c5dppqinjueqvo8m1k3frf6mo